Leniolisib
CAS 1354690-24-6Small Molecule
Overview
Leniolisib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3643413).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Leniolisib expires 19 Feb 2032 and exclusivity 24 Mar 2030. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 1-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)-3-pyridinyl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one
- Canonical SMILES
- CCC(=O)N1CC[C@@H](C1)NC2=NC=NC3=C2CN(CC3)C4=CC(=C(N=C4)OC)C(F)(F)F
- InChIKey
- MWKYMZXCGYXLPL-ZDUSSCGKSA-N
Verified Supplier Partner
Do you supply Leniolisib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.